LM Advisors LLC Sells 5,460 Shares of iShares Biotechnology ETF $IBB

LM Advisors LLC decreased its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 83.1% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 1,109 shares of the financial services provider’s stock after selling 5,460 shares during the period. LM Advisors LLC’s holdings in iShares Biotechnology ETF were worth $187,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also modified their holdings of IBB. Citigroup Inc. boosted its holdings in shares of iShares Biotechnology ETF by 40.9% during the 4th quarter. Citigroup Inc. now owns 5,242,688 shares of the financial services provider’s stock worth $884,808,000 after buying an additional 1,521,992 shares during the period. BNP Paribas Financial Markets boosted its holdings in shares of iShares Biotechnology ETF by 313.2% during the 3rd quarter. BNP Paribas Financial Markets now owns 1,915,395 shares of the financial services provider’s stock worth $276,526,000 after buying an additional 1,451,820 shares during the period. WestEnd Advisors LLC bought a new stake in shares of iShares Biotechnology ETF during the 4th quarter worth about $106,276,000. Truist Financial Corp boosted its holdings in shares of iShares Biotechnology ETF by 2,239.6% during the 4th quarter. Truist Financial Corp now owns 642,023 shares of the financial services provider’s stock worth $108,354,000 after buying an additional 614,582 shares during the period. Finally, LPL Financial LLC boosted its holdings in shares of iShares Biotechnology ETF by 145.9% during the 4th quarter. LPL Financial LLC now owns 992,799 shares of the financial services provider’s stock worth $167,555,000 after buying an additional 589,033 shares during the period. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Up 0.1%

Shares of iShares Biotechnology ETF stock opened at $170.66 on Friday. iShares Biotechnology ETF has a twelve month low of $123.61 and a twelve month high of $179.64. The company has a 50-day simple moving average of $170.28 and a two-hundred day simple moving average of $170.65.

iShares Biotechnology ETF Cuts Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 20th. Shareholders of record on Tuesday, March 17th were paid a $0.1218 dividend. The ex-dividend date was Tuesday, March 17th. This represents a $0.49 annualized dividend and a yield of 0.3%.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.